Robuta

https://www.fool.com/investing/2018/06/07/is-valeant-pharmaceuticals-international-inc-a-buy.aspx
The drugmaker hopes to keep its recent momentum going. But will Valeant's sizzle fizzle?
valeant pharmaceuticalsmotley foolinternationalincbuy
https://www.fool.com/investing/general/2014/05/11/valeant-pharmaceuticalss-earnings-take-a-back-seat.aspx
Valeant's miss on sales is likely to go almost unnoticed in its pursuit of Allergan
valeant pharmaceuticalsback seatearningstakeallergan
https://www.fool.com/investing/general/2015/12/01/why-valeant-pharmaceuticals-intl-inc-is-up-today.aspx
The drugmaker is making a comeback off its lows.
valeant pharmaceuticalsintlinctodaymotley
https://www.pharmacytimes.com/view/trending-news-today-fraud-lawsuit-filed-against-valeant-pharmaceuticals
Top news of the day from across the healthcare landscape.
trending newsvaleant pharmaceuticalstodayfraudlawsuit